search
Back to results

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1

Primary Purpose

Cocaine-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Buprenorphine
Sponsored by
Yale University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Opioid-Related Disorders

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Please contact site for information.

Sites / Locations

  • APT Residential Services Division

Outcomes

Primary Outcome Measures

Depression
Withdrawal symptoms
Opioid and cocaine use
Social and psychological functioning
AIDS risk behavior

Secondary Outcome Measures

Full Information

First Posted
September 20, 1999
Last Updated
June 24, 2020
Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00000216
Brief Title
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Official Title
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to compare the clinical efficacy of maintenance on low and high doses of buprenorphine with methadone for cocaine abusing opiate addicts.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders
Keywords
Opioid-Related Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Enrollment
0 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Buprenorphine
Primary Outcome Measure Information:
Title
Depression
Title
Withdrawal symptoms
Title
Opioid and cocaine use
Title
Social and psychological functioning
Title
AIDS risk behavior

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard Schottenfeld, M.D.
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
APT Residential Services Division
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
9283506
Citation
Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug;54(8):713-20. doi: 10.1001/archpsyc.1997.01830200041006.
Results Reference
background

Learn more about this trial

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1

We'll reach out to this number within 24 hrs